Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
RaQualia Pharma 9-Mos Loss Y493.00M Vs Loss Y568.00M
RaQualia Pharma Inc. (4579.TO) Japan Nine Months Ended September 30 GROUP 2026 2025 Revenue Y2.35 bln Y2.31 bln Operating Profit (Y238.00 mln) (Y344.00 mln) Pretax Profit (Y261.00 mln) (Y426.00 mln) Net Profit (Y493.00 mln) (Y568.00 mln) Per share…
Kubota Pharma 9-Mos Loss Y908.00M Vs Loss Y435.00M
Kubota Pharmaceutical Holdings Co. Ltd. (4596.TO) Japan Nine Months Ended September 30 GROUP 2026 2025 Revenue Y11.00 mln Y18.00 mln Operating Profit (Y911.00 mln) (Y654.00 mln) Pretax Profit (Y908.00 mln) (Y435.00 mln) Net Profit (Y908.00 mln)…
Acurx Pharma (ACXP) Q3 2026 Earnings Call Transcript
Chief Financial Officer - Robert G. Shawah President and CEO - David Luci Executive Chairman - Bob DeLuccia Senior Medical Advisor - Dr. Michael Silverman Cash Balance -- $9.7 million as of Sept. 30, 2026, compared to $7.6 million on Dec. 31, 2025.
Fennec Pharma (FENC) Q3 2026 Earnings Call Transcript
Chief Financial Officer - Robert C. Andrade Chief Executive Officer and board member - Jeffrey S. Hackman Net Product Sales -- $19.4 million, representing an increase of approximately 56% year over year. Non-GAAP Adjusted EBITDA -- $5.8 million…
Royalty Pharma (NASDAQ:RPRX) Stock Rating Upgraded by Zacks Research
Royalty Pharma (NASDAQ:RPRX - Get Free Report) was upgraded by equities researchers at Zacks Research from a 'hold' rating to a 'strong-buy' rating in a research note issued to investors on Wednesday, Zacks reports. How Royalty Pharma Prints Cash…
Spyglass Pharma (NASDAQ:SGP) Stock Price Target Raised at Stifel Nicolaus
Spyglass Pharma (NASDAQ:SGP - Get Free Report) had its price objective upped by stock analysts at Stifel Nicolaus from $42.00 to $44.00 in a research note issued on Friday, Benzinga reports. The firm presently has a 'buy' rating on the stock.
Ascendis Pharma A/S (NASDAQ:ASND) Given New $315.00 Price Target at Cantor Fitzgerald
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) had its price target upped by investment analysts at Cantor Fitzgerald from $300.00 to $315.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has an 'overweight'…
Canaccord Genuity Group Issues Positive Forecast for Ascendis Pharma A/S (NASDAQ:ASND) Stock Price
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) had its price target upped by analysts at Canaccord Genuity Group from $268.00 to $274.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a 'hold'…
HC Wainwright Has Lowered Expectations for Ascendis Pharma A/S (NASDAQ:ASND) Stock Price
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) had its price objective dropped by HC Wainwright from $344.00 to $335.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a 'buy' rating on the biotechnology…
Ascendis Pharma A/S (NASDAQ:ASND) Posts Earnings Results
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) posted its quarterly earnings data on Thursday. The biotechnology company reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $1.05, FiscalAI…
Ascendis Pharma A/S Q3 Earnings Call Highlights
Can BioMarin Stock Live Up to Wall Street's High Expectations? Ascendis Pharma A/ S NASDAQ: ASND reported third-quarter product revenue of EUR 366 million, up 89% from a year earlier, as sales of hypoparathyroidism treatment YORVIPATH and recently…
HC Wainwright Issues Positive Forecast for Spyglass Pharma (NASDAQ:SGP) Stock Price
Spyglass Pharma (NASDAQ:SGP - Get Free Report) had its price target hoisted by equities researchers at HC Wainwright from $37.00 to $43.00 in a report released on Thursday, Benzinga reports. The firm presently has a 'buy' rating on the stock. HC…
Avalyn Pharma (NASDAQ:AVLN) Stock: Insider Fmr Llc Sells 175,000 Shares
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) insider Fmr Llc sold 175,000 shares of the firm's stock in a transaction on Monday, November 9th. The stock was sold at an average price of $29.07, for a total value of $5,087,250.00. Following the…
Avalyn Pharma (NASDAQ:AVLN) Insider Fmr Llc Sells 53,454 Shares of Company Stock
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) insider Fmr Llc sold 53,454 shares of the company's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $30.21, for a total value of $1,614,845.34.
Kennedy's Future: Will Democrats Try to Impeach Him, or Actually Work With Him?
Three days after last week's “blue wave” election, Health Secretary Robert F. Kennedy Jr. posted a warning on X to anyone suspecting his Make America Healthy Again movement had been weakened. “It's time to unleash the…
Receive a Daily briefing on Pharma Industry News
Get Started